<prompt> Answer this question truthfullyHow do PCSK9 inhibitors such as alirocumab and evolocumab work to decrease LDL levels?  <response>: <reason> PCSK9 inhibitors e.g. alirocumab and evolocumab work by inactivating LDL-receptor degradation, resulting in a dramatic decrease in LDL. 